sponsored
PatientsVille.com Logo

PatientsVille

Venom Medical Research Studies

Up-to-date List of Venom Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Venom Medical Research Studies

Rank Status Study
1 Unknown  Bee Venom Acupuncture for the Treatment of Chronic Low Back Pain
Condition: Chronic Low Back Pain
Interventions: Procedure: Bee Venom Acupuncture Therapy;   Drug: Loxoprofen;   Procedure: Placebo
Outcome Measures: Visual Analogue Scale for bothersomeness;   Visual Analogue Scale for pain intensity;   Disability scores on Oswestry Disability Index;   Quality of Life scores on EQ-5D;   Depression scores on Beck Depression Inventory
2 Unknown  East-West Collaborative Medicine Using Bee-Venom Acupuncture on Whiplash-Associated Disorders
Condition: Whiplash Injuries
Interventions: Device: Bee Venom Acupuncture Therapy;   Drug: zaltoprofen
Outcome Measures: pain scores on Visual Analogue Scale;   neck disability scores on Neck Disability Index;   depression scores on Beck Depression Inventory;   quality of life scores on short form SF-36;   quality of life scores on EQ-5D
3 Recruiting Efficacy of Acupuncture and Bee Venom Acupuncture on Patients With Idiopathic Parkinson's Disease
Condition: Idiopathic Parkinson's Disease
Interventions: Procedure: acupuncture and bee Venom acupuncture point injection;   Procedure: sham acupuncture and normal saline injections
Outcome Measure: Change of the Unified Parkinson's Disease Rating Scale (UPDRS) parts II and III
4 Recruiting East-West Collaboration Treatment Using Bee Venom Acupuncture and NSAIDs for Chronic Cervicalgia
Condition: Chronic Non-specific, Uncomplicated Neck Pain
Interventions: Procedure: Bee Venom Acupuncture;   Drug: Loxoprofen
Outcome Measures: Visual Analogue Scale for bothersomeness;   Neck Disability Index;   Depression scores on Beck's Depression Inventory;   Quality of Life scores on EQ-5D;   Quality of Life scores on SF-36;   Visual Analogue Scale for pain intensity;   Safety profile;   Credibility test
5 Unknown  Safety and Efficacy Study of Bee Venom to Treat Knee Osteoarthritis
Condition: Persons With Mild to Moderate Knee Osteoarthritis
Intervention: Procedure: Injecting bee Venom as a treatment for OA
Outcome Measures: Change in Visual Analog Scale;   Change in Knee Injury and Osteoarthritis Outcome Score;   Change in use of analgesic meds after 6 weeks of treatment;   Change in 50 ft. walk and 4 step up/down climb time;   Adverse event incidence;   Baseline and visit 12 laboratory assessments;   Change in tenderness and motion
6 Recruiting The Effectiveness of Non-surgical Integrative Package on Failed Back Surgery Syndrome
Condition: Failed Back Surgery Syndrome
Interventions: Drug: Chuna herbal medicine;   Procedure: Chuna manual therapy;   Procedure: Acupuncture;   Procedure: Bee-Venom pharmacoacupuncture
Outcome Measures: VAS of low back pain;   VAS of radiating leg pain;   ODI (Oswestry Disability Index);   SF-36 (Quality of Life);   General assessment(patient/doctor)
7 Recruiting Emergency Treatment of Coral Snake EnVenomation With AntiVenom
Conditions: Coral Snake Bite;   Toxic Effect of Coral Snake Venom
Intervention: Drug: Snake (Micrurus) North American immune F(ab')2 Equine
Outcome Measures: Survival through study period;   Decrease in plasma Venom and antiVenom levels
8 Unknown  Efficacy of Ipomea Pes-caprae Ointment as an add-on Therapy in Patient With Jellyfish Dermatitis
Conditions: Jellyfish Dermatitis;   Jellyfish Venoms
Intervention: Drug: Ipomea pes-caprae ointment
Outcome Measure: Healing time of the Jellyfish dermatitis lesion (days)
9 Unknown  Study to Evaluate the Efficacy of Two Treatment Schemes With Antivipmyn ® for the Treatment of Snake Bite EnVenomation
Condition: Snake Bite
Intervention: Biological: Antivipmyn ®
Outcome Measures: Resolution of systemic signs and symptoms of snake bite enVenomation expressed as % of patients requiring additional antiVenom and % of patients that are stable;   Evaluate the correlation between Dry Tube Test and Coagulation Test (PT, INR, PTT, platelets and fibrinogen);   Evaluate Venom and AntiVenom Levels with the other parameters;   Evaluate the possible relation of the serum markers (LDH, CPK, metalloproteinases)and local damage evolution.
10 Recruiting Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies.
Conditions: Healthy Volunteers;   Children With HSP;   Subject With Allergy;   Lymphoma
Intervention: Biological: a blood sample
Outcome Measure: the percentage of allele B
11 Recruiting A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® Versus Placebo With Rescue Treatment for Copperhead Snake EnVenomation
Condition: Agkistrodon Contortrix EnVenomation
Interventions: Biological: crotilidae polyvalent immune fab (ovine);   Biological: Placebo
Outcome Measure: Patient Specific Functional Scale at Day 14
12 Recruiting The Natural History of Human Stingray Injuries
Conditions: Stingray Injury;   Marine EnVenomation
Intervention:
Outcome Measure: Incidence and duration of particular symptoms, medical evaluations, and treatment
13 Unknown  A Trial of Equine F (ab')2 AntiVenom for Treatment of Scorpion EnVenomation in Morocco
Condition: Poisoning by Scorpion Sting
Interventions: Biological: equine F(ab')2 antiVenom;   Other: Standard of care plus placebo
Outcome Measures: To demonstrate the effectiveness of Alacramyn NAMO in the treatment of scorpion enVenomation by reducing the severity of enVenomation;   Effectiveness of Alacramyn NAMO in the treatment of scorpion enVenomation by reducing the severity of enVenomation.
14 Unknown  Anfibatide Phase Ib-IIa Clinical Trial
Condition: Non-ST Segment Elevation Myocardial Infarction
Interventions: Drug: Anfibatide;   Drug: Placebo
Outcome Measures: Thrombosis formation;   Mortality;   Safety endpoints;   Safety Endpoints
15 Recruiting Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
Condition: Osteoarthritis of the Knee
Interventions: Biological: Apitox, purified honeybee toxin, lyophilized in saline;   Biological: histamine
Outcome Measures: WOMAC;   PhGA;   PGA
16 Unknown  The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes
Intervention: Biological: rExenatide-4
Outcome Measures: To compare treatment arms in terms of change from baseline to endpoint in HbA1c;   To compare treatment arms in terms of change from baseline to endpoint in GA;   To compare treatment arms in terms of change from baseline to endpoint in fasting serum glucose;   To compare treatment arms in terms of change from baseline to endpoint in postprandial blood glucose 2-hour;   To compare treatment arms in terms of change from baseline to endpoint in body weight

These studies may lead to new treatments and are adding insight into Venom etiology and treatment.

A major focus of Venom research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.


Discuss Venom